These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2423985

  • 1. Amiodarone: value of programmed electrical stimulation and Holter monitoring.
    Fisher JD, Kim SG, Waspe LE, Johnston DR.
    Pacing Clin Electrophysiol; 1986 May; 9(3):422-35. PubMed ID: 2423985
    [Abstract] [Full Text] [Related]

  • 2. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
    Marchlinski FE, Buxton AE, Flores BT, Doherty JU, Waxman HL, Josephson ME.
    Am J Cardiol; 1985 Mar 01; 55(6):709-12. PubMed ID: 3976513
    [Abstract] [Full Text] [Related]

  • 3. Ventricular arrhythmias: use of electrophysiologic studies.
    Horowitz LN, Spielman SR, Greenspan AM, Webb CR, Kay HR.
    Am Heart J; 1983 Oct 01; 106(4 Pt 2):881-6. PubMed ID: 6613834
    [Abstract] [Full Text] [Related]

  • 4. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP, Reid PR, Platia EV, Griffith LS.
    Am J Cardiol; 1985 Feb 01; 55(4):375-9. PubMed ID: 3969872
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A, Di Pede F, Gasparini G, Zanocco A, Delise P, Bonso A, D'Este D, Piccolo E.
    G Ital Cardiol; 1991 Mar 01; 21(3):259-69. PubMed ID: 1894120
    [Abstract] [Full Text] [Related]

  • 6. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
    Hamer AW, Finerman WB, Peter T, Mandel WJ.
    Am Heart J; 1981 Dec 01; 102(6 Pt 1):992-1000. PubMed ID: 7315716
    [Abstract] [Full Text] [Related]

  • 7. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K, Singh BN, Hendrickson J, Intarachot V, Lopez B, Feld G, Cannom DS, Weiss JL.
    Ann Intern Med; 1983 May 01; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [Abstract] [Full Text] [Related]

  • 8. Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
    Kim SG, Felder SD, Figura I, Johnston DR, Waspe LE, Fisher JD.
    J Am Coll Cardiol; 1987 Feb 01; 9(2):398-404. PubMed ID: 3805529
    [Abstract] [Full Text] [Related]

  • 9. Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy.
    Reddy CP, Kuo CS, Jivrajka V.
    Pacing Clin Electrophysiol; 1984 Nov 01; 7(6 Pt 1):1055-62. PubMed ID: 6209624
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.
    Fananapazir L, Epstein SE.
    Am J Cardiol; 1991 Jan 15; 67(2):175-82. PubMed ID: 1987719
    [Abstract] [Full Text] [Related]

  • 12. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
    Morady F, Scheinman MM, Hess DS.
    Pacing Clin Electrophysiol; 1983 May 15; 6(3 Pt 1):609-15. PubMed ID: 6191299
    [Abstract] [Full Text] [Related]

  • 13. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
    Yazaki Y, Haffajee CI, Gold RL, Bishop RL, Alpert JS.
    Am J Cardiol; 1987 Aug 01; 60(4):293-7. PubMed ID: 3618488
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class 1A antiarrhythmic agent.
    Kim SG, Felder SD, Figura I, Johnston DR, Mercando AD, Fisher JD.
    Am J Cardiol; 1987 Jun 01; 59(15):1314-8. PubMed ID: 3591686
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E, Krikler DM.
    Br Heart J; 1980 Jul 01; 44(1):82-90. PubMed ID: 7426165
    [Abstract] [Full Text] [Related]

  • 16. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN.
    Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357
    [Abstract] [Full Text] [Related]

  • 17. Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis.
    Roberts SA, Viana MA, Nazari J, Bauman JL.
    Pacing Clin Electrophysiol; 1994 Oct 01; 17(10):1590-602. PubMed ID: 7800560
    [Abstract] [Full Text] [Related]

  • 18. Clinical use and pharmacology of amiodarone.
    Heger JJ, Prystowsky EN, Miles WM, Zipes DP.
    Med Clin North Am; 1984 Sep 01; 68(5):1339-66. PubMed ID: 6387328
    [Abstract] [Full Text] [Related]

  • 19. QT prolongation and the antiarrhythmic efficacy of amiodarone.
    Torres V, Tepper D, Flowers D, Wynn J, Lam S, Keefe D, Miura DS, Somberg JC.
    J Am Coll Cardiol; 1986 Jan 01; 7(1):142-7. PubMed ID: 3941202
    [Abstract] [Full Text] [Related]

  • 20. [The place of amiodarone in 1979 in the therapeutic arsenal of a cardiac intensive care unit].
    Demoulin JC, Legrand V.
    Rev Med Liege; 1979 Dec 01; 34(23):963-8. PubMed ID: 550265
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.